A top medical researcher at the University of Minnesota has found a new way to reverse memory loss in lab mice, a discovery that could set the stage for a potential human treatment.
Dr. Karen Ashe, a world-renowned expert on Alzheimer's disease, said the research shows that it may be possible for the brain to repair itself, even after the signs of memory loss have appeared.
In a study published this week in the journal Nature Medicine, Ashe and her team found that a natural enzyme called caspase-2 plays a key role in dementia. By lowering the enzyme level, they were able to reverse the memory loss in mice that were genetically altered to mimic the disease.
"Of all the discoveries I've made in my labs, this one has the most potential for becoming an effective drug," said Ashe, who is director of the university's N. Bud Grossman Center for Memory Research and Care.
But she cautioned that it would take years to turn the discovery into a real treatment for patients. "We're trying to develop a pill that would block caspase, but it's a 10-year process even if we're successful," she said.
James A. Hendrix, a scientific director at the Alzheimer's Association, called it an exciting finding, saying, "This could be a new target for drug therapy."
He said the study shed new light on the process that causes Alzheimer's, which has stubbornly defied most efforts at treatment.
But he, too, struck a note of caution. "One has to remember that this [research] is on mice," he said. "We have, unfortunately, successfully treated mice and rats for years, and that hasn't translated to humans. So for a treatment, there's still a long way to go."